Resource type
Date created
2018-03-26
Authors/Contributors
Author (aut): Lianping, T.
Author (aut): Socias, M.E.
Author (aut): Wood, E.
Author (aut): Milloy, M-J.
Author (aut): Nosova, K.
Author (aut): DeBeck, K.
Author (aut): Kerr, T.
Author (aut): Hayashi, K.
Abstract
Background & aims People who inject drugs (PWID) living with hepatitis C virus (HCV) infection often experience barriers to accessing HCV treatment and care. New, safer and more effective directacting antiviral-based therapies offer an opportunity to scale-up HCV-related services. Methadone maintenance therapy (MMT) programs have been shown to be effective in linking PWID to health and support services, largely in the context of HIV. The objective of the study was to examine the relationship between being enrolled in MMT and having access to regular physician care regarding HCV among HCV antibody-positive PWID in Vancouver, Canada.
Document
Published as
Ti L, Socı´as ME, Wood E, Milloy M-J, Nosova E, DeBeck K, et al. (2018) The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs. PLoS ONE 13(3): e0194162. https://doi.org/10.1371/journal.pone.0194162
Publication details
Publication title
PLoS ONE
Document title
The Impact of Methadone Maintenance Therapy on Access to Regular Physician Care Regarding Hepatitis C Among People who Inject Drugs
Date
2018
Volume
13
Issue
3
Published article URL
Rights (standard)
Copyright statement
Copyright is held by the author(s).
Scholarly level
Peer reviewed?
Yes
Funder
Funder (spn): United States National Institutes of Health (NIH)
Funder (spn): Canadian Institutes of Health Research (CIHR)
Language
English
Member of collection
Download file | Size |
---|---|
the_impact_of_methadone.pdf | 644.96 KB |